Search research articles
Contact Us
Filters
Showing results (41-50 of 122) with videos related to
Page
of 13
Sort By:
Experimental Hematology
|
November 3, 2005
Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood
Wolfgang Wagner, Frederik Wein, Anja Seckinger, et al.
Blood Cancer Journal
|
February 17, 2018
Upregulation of FOXM1 in a subset of relapsed myeloma results in poor outcome
Chunyan Gu, Carol Holman, Ramakrishna Sompallae, et al.
Experimental Hematology
|
August 19, 2007
Primitive and committed human hematopoietic progenitor cells interact with primary murine neural cells and are induced to undergo self-renewing cell divisions
Sandra Gottschling, Volker Eckstein, Rainer Saffrich, et al.
Leukemia
|
November 13, 2019
Cytogenetic subclone formation and evolution in progressive smoldering multiple myeloma
Maximilian Merz, Thomas Hielscher, David Schult, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 23, 2013
Progression in smoldering myeloma is independently determined by the chromosomal abnormalities del(17p), t(4;14), gain 1q, hyperdiploidy, and tumor load
Kai Neben, Anna Jauch, Thomas Hielscher, et al.
Stem Cells (Dayton, Ohio)
|
June 6, 2007
Atrial-radiofrequency catheter ablation mediated targeting of mesenchymal stromal cells
Patrick A Schweizer, Ulf Krause, Ruediger Becker, et al.
BMC Medical Genomics
|
December 31, 2015
Profound impact of sample processing delay on gene expression of multiple myeloma plasma cells
Tobias Meißner, Anja Seckinger, Kari Hemminki, et al.
Journal of Biomedicine & Biotechnology
|
June 2, 2007
The many facets of SDF-1alpha, CXCR4 agonists and antagonists on hematopoietic progenitor cells
Anne Faber, Christoph Roderburg, Frederik Wein, et al.
JCO Precision Oncology
|
July 10, 2024
Quantitative Integrative Survival Prediction in Multiple Myeloma Patients Treated With Bortezomib-Based Induction, High-Dose Therapy and Autologous Stem Cell Transplantation
Manuela Hummel, Thomas Hielscher, Martina Emde-Rajaratnam, et al.
Stem Cells and Development
|
March 14, 2007
Intravenous delivery of autologous mesenchymal stem cells limits infarct size and improves left ventricular function in the infarcted porcine heart
Ulf Krause, Christoph Harter, Anja Seckinger, et al.
Page
of 13
Search research articles
Search
Showing results (41-50 of 122) with videos related to
Sort By:
Page
of 13
Experimental Hematology
|
November 3, 2005
Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood
Wolfgang Wagner, Frederik Wein, Anja Seckinger, et al.
Blood Cancer Journal
|
February 17, 2018
Upregulation of FOXM1 in a subset of relapsed myeloma results in poor outcome
Chunyan Gu, Carol Holman, Ramakrishna Sompallae, et al.
Experimental Hematology
|
August 19, 2007
Primitive and committed human hematopoietic progenitor cells interact with primary murine neural cells and are induced to undergo self-renewing cell divisions
Sandra Gottschling, Volker Eckstein, Rainer Saffrich, et al.
Leukemia
|
November 13, 2019
Cytogenetic subclone formation and evolution in progressive smoldering multiple myeloma
Maximilian Merz, Thomas Hielscher, David Schult, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 23, 2013
Progression in smoldering myeloma is independently determined by the chromosomal abnormalities del(17p), t(4;14), gain 1q, hyperdiploidy, and tumor load
Kai Neben, Anna Jauch, Thomas Hielscher, et al.
Stem Cells (Dayton, Ohio)
|
June 6, 2007
Atrial-radiofrequency catheter ablation mediated targeting of mesenchymal stromal cells
Patrick A Schweizer, Ulf Krause, Ruediger Becker, et al.
BMC Medical Genomics
|
December 31, 2015
Profound impact of sample processing delay on gene expression of multiple myeloma plasma cells
Tobias Meißner, Anja Seckinger, Kari Hemminki, et al.
Journal of Biomedicine & Biotechnology
|
June 2, 2007
The many facets of SDF-1alpha, CXCR4 agonists and antagonists on hematopoietic progenitor cells
Anne Faber, Christoph Roderburg, Frederik Wein, et al.
JCO Precision Oncology
|
July 10, 2024
Quantitative Integrative Survival Prediction in Multiple Myeloma Patients Treated With Bortezomib-Based Induction, High-Dose Therapy and Autologous Stem Cell Transplantation
Manuela Hummel, Thomas Hielscher, Martina Emde-Rajaratnam, et al.
Stem Cells and Development
|
March 14, 2007
Intravenous delivery of autologous mesenchymal stem cells limits infarct size and improves left ventricular function in the infarcted porcine heart
Ulf Krause, Christoph Harter, Anja Seckinger, et al.
Page
of 13